Biota Pharmaceuticals IncAdd to My Watchlist

BOTA:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 2.34
    Last
  • 0.04  1.74%
    Today's Change
  • 2.30
    Previous Close
  • Today
     
    2.10
    6.10
    52 Week Low - High
8:10 pm ET 4/1/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding35 million
Market Cap$82 million
Return on Equity ttm-10.10%
Last Dividend$6.65
Dividend Yield ttm--
Relative Dividend Yield benchmark--
Dividend Ex-Date11/9/12
Dividend Pay Date11/8/12
Earnings
EPS: Year Actual ttm-0.172
EPS: Year Est. 6/15 ttm--
 
EPS: Quarterly Actual 12/14 0.19
EPS: Quarterly Est. 3/15 --
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-10.97
Company Description
Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.
Revenue$69 million
Net Income$-11 million
Total Assets$114 million
Employees66
Web Sitewww.biotapharma.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!